|Articles|May 1, 2001
Supplements and Featured Publications
- Artherosclerosis: Achieving Optimal Outcomes in Statin Therapy
- Volume 7
- Issue 5 Suppl
Surrogate Endpoints and Newer Risk Markers in Atherosclerosis Management
Author(s)Christie M. Ballantyne, MD
Advertisement
Articles in this issue
about 25 years ago
Participating Facultyabout 25 years ago
Introductionabout 25 years ago
Should All Patients with Cardiovascular Disease Receive Statin Therapy?about 25 years ago
Threshold Level or Not for Low-Density Lipoprotein Cholesterolabout 25 years ago
Statins--Differences and Similaritiesabout 25 years ago
What Do the Statin Trials Tell Us?about 25 years ago
New Therapies on the Horizonabout 25 years ago
A New Statin: A New StandardAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
2
Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS
3
Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship
4
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
5